The Anti-inflammatory Agent N-acetyl Cysteine Exacerbates Endotoxin-induced Hypoxemia and Hypotension and Induces Polycythemia in the Ovine Fetus
Overview
Authors
Affiliations
Background: Lipopolysaccharide (LPS) delivered acutely to the ovine fetus induces cerebral white matter injury and brain inflammation. N-acetyl cysteine (NAC) is potentially neuroprotective as it blocks the production of inflammatory cytokines and increases glutathione levels; however, it is unknown whether NAC affects the physiological status of the fetus already exposed to an inflammatory environment.
Objectives: Our objective was to determine whether NAC influences the physiological effects of LPS exposure in the ovine fetus.
Methods: Catheterized fetal sheep underwent one of four treatments (saline, n = 6; LPS, n = 6; LPS + NAC, n = 6; NAC, n = 3) on 5 consecutive days from 95 days of gestation (term approximately 147 days). Fetal arterial pressure and heart rate were recorded and blood samples collected.
Results: LPS administration resulted in fetal hypoxemia and hypotension; simultaneous treatment with NAC exacerbated these effects and induced polycythemia. NAC treatment alone had no effect on the fetus.
Conclusion: In the presence of LPS, NAC compromises fetal physiological status, suggesting that it may not be a suitable antenatal treatment for a fetus with evidence of inflammation.
Zhang Z, Lin Y, Kim S, Su L, Liu J, Kannan R J Neuroinflammation. 2020; 17(1):319.
PMID: 33100217 PMC: 7586697. DOI: 10.1186/s12974-020-01984-1.
Buhimschi C, Bahtiyar M, Zhao G, Abdelghany O, Schneider L, Razeq S Pediatr Res. 2020; 89(1):175-184.
PMID: 32818949 PMC: 7451831. DOI: 10.1038/s41390-020-01106-w.
Chao M, Chen C, Yang Y, Chuang Y, Chu T, Tseng C Sci Rep. 2016; 6:32373.
PMID: 27577752 PMC: 5006028. DOI: 10.1038/srep32373.
Jenkins D, Wiest D, Mulvihill D, Hlavacek A, Majstoravich S, Brown T J Pediatr. 2015; 168:67-76.e6.
PMID: 26545726 PMC: 4698030. DOI: 10.1016/j.jpeds.2015.09.076.
New antioxidant drugs for neonatal brain injury.
Tataranno M, Perrone S, Longini M, Buonocore G Oxid Med Cell Longev. 2015; 2015:108251.
PMID: 25685254 PMC: 4313724. DOI: 10.1155/2015/108251.